Ireland: Medicaments Containing Insulin Market 2023

Medicaments Containing Insulin Market Size in Ireland

In 2021, the Irish medicaments containing insulin market decreased by -0.2% to $X, falling for the second consecutive year after two years of growth. Overall, consumption, however, recorded a abrupt shrinkage. Over the period under review, the market attained the peak level at $X in 2019; however, from 2020 to 2021, consumption failed to regain momentum.

Medicaments Containing Insulin Production in Ireland

In value terms, medicaments containing insulin production amounted to less than $X in 2021 estimated in export price. Overall, production saw a precipitous contraction. The pace of growth was the most pronounced in 2016 with a decrease of -40.3% against the previous year. Medicaments containing insulin production peaked at $X in 2014; however, from 2015 to 2021, production remained at a lower figure.

Medicaments Containing Insulin Exports

Exports from Ireland

Medicaments containing insulin exports from Ireland skyrocketed to X tons in 2021, growing by 160% against 2020 figures. Over the period under review, exports showed a significant expansion. As a result, the exports reached the peak and are likely to continue growth in the immediate term.

In value terms, medicaments containing insulin exports contracted modestly to $X in 2021. In general, exports continue to indicate a significant increase. The exports peaked at $X in 2020, and then declined in the following year.

Exports by Country

The Netherlands (X kg) was the main destination for medicaments containing insulin exports from Ireland, accounting for a 82% share of total exports. Moreover, medicaments containing insulin exports to the Netherlands exceeded the volume sent to the second major destination, the UK (X kg), fivefold.

From 2015 to 2021, the average annual growth rate of volume to the Netherlands totaled +131.8%.

In value terms, the Netherlands ($X) remains the key foreign market for medicaments containing insulin but not antibiotics exports from Ireland, comprising 82% of total exports. The second position in the ranking was taken by the UK ($X), with an 18% share of total exports.

From 2015 to 2021, the average annual rate of growth in terms of value to the Netherlands amounted to -17.1%.

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2021, declining by -62.2% against the previous year. Over the period under review, the export price, however, recorded a mild increase. The export price peaked at $X per ton in 2020, and then fell rapidly in the following year.

Average prices varied noticeably for the major external markets. In 2021, amid the top suppliers, the country with the highest price was the UK ($X per ton), while the average price for exports to the Netherlands stood at $X per ton.

From 2015 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to the UK (+17.6%).

Medicaments Containing Insulin Imports

Imports into Ireland

In 2021, overseas purchases of medicaments containing insulin but not antibiotics decreased by -46.6% to X kg, falling for the second year in a row after five years of growth. Over the period under review, imports recorded a deep slump. The pace of growth appeared the most rapid in 2019 when imports increased by 1,998%. Over the period under review, imports hit record highs at X tons in 2012; however, from 2013 to 2021, imports remained at a lower figure.

In value terms, medicaments containing insulin imports fell significantly to $X in 2021. Overall, imports continue to indicate a deep downturn. The most prominent rate of growth was recorded in 2018 when imports increased by 564%. Imports peaked at $X in 2019; however, from 2020 to 2021, imports remained at a lower figure.

Imports by Country

In 2021, Romania (X kg) constituted the largest supplier of medicaments containing insulin to Ireland, accounting for a 79% share of total imports. Moreover, medicaments containing insulin imports from Romania exceeded the figures recorded by the second-largest supplier, the Czech Republic (X kg), ninefold. The third position in this ranking was taken by the UK (X kg), with a 7.5% share.

From 2012 to 2021, the average annual growth rate of volume from Romania amounted to +189.7%. The remaining supplying countries recorded the following average annual rates of imports growth: the Czech Republic (+3.4% per year) and the UK (-34.3% per year).

In value terms, Romania ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to Ireland, comprising 82% of total imports. The second position in the ranking was held by the Czech Republic ($X), with an 8.8% share of total imports. It was followed by the UK, with a 7.1% share.

From 2012 to 2021, the average annual growth rate of value from Romania stood at +189.8%. The remaining supplying countries recorded the following average annual rates of imports growth: the Czech Republic (+7.8% per year) and the UK (-33.2% per year).

Import Prices by Country

In 2021, the average medicaments containing insulin import price amounted to $X per ton, with a decrease of -34.3% against the previous year. In general, the import price, however, enjoyed perceptible growth. The pace of growth was the most pronounced in 2018 when the average import price increased by 159%. As a result, import price attained the peak level of $X per ton. From 2019 to 2021, the average import prices remained at a somewhat lower figure.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was the Czech Republic ($X per ton), while the price for the Netherlands ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by the United States (+38.5%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :